Wag-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, alleviating mild to moderate pain and reducing fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation, enhancing tissue healing. This combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and postoperative inflammation. Wag-SP Tablet is effective in providing symptomatic relief from pain, swelling, and inflammation associated with these conditions. It should be used under medical supervision, with caution advised in patients with gastrointestinal ulcers, bleeding disorders, hepatic or renal impairment, and hypersensitivity to any component. The dosage and duration of therapy should be tailored to the individual patient’s clinical condition. Regular monitoring is recommended to minimize potential adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic dysfunction.